CHATHAM, N.J. - Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP), a clinical-stage biotech company with a market capitalization of $28 million, announced today positive outcomes from its Phase 1 ...

DUBLIN - Trinity Biotech plc (NASDAQ:TRIB), a leader in diabetes management solutions currently trading at $0.86 per share, has announced significant enhancements in the performance of its continuous ...

The platform enables direct, unbiased genome-wide identification and quantification of the exact position of double strand DNA breaks in edited cells.

PARISH — Assembly Minority Leader Will Barclay (R,C-Pulaski) recently toured BioSpherix, a biotechnology research company ...

Blueprint Medicines (NASDAQ:BPMC – Get Free Report) had its price target upped by equities research analysts at JPMorgan ...

Analysts at HC Wainwright increased their FY2024 earnings per share estimates for shares of Evaxion Biotech A/S in a note issued to investors on Monday, February 3rd. HC Wainwright analyst S.

Concerned constituents in Massachusetts who have been turning to their representatives in Congress to voice concerns about ...

Biotechnology company Tidal Vision said it closed an oversubscribed $140 million Series B financing round. Participants in the round included Cambridge Companies SPG, Eni Next, Convent Capital, and ...

Crown Laboratories and its affiliate Reba Merger Sub will now pay for the shares, which will cost the company $314.6 million.

Of the 102 company launches or series A financings since October 2023, just nine had a woman at the helm, according to a ...

Nashville-based aesthetics biotech company Revance Therapeutics announced Wednesday that a planned merging with Johnson City, ...

Aurion Biotech, Inc. plans $100M IPO for corneal disease treatments, limited competition, Phase 1/2 trials underway with ...